NAVIDEA BIOPHARMACEUTICALS I (NAVB) Stock Technical Analysis
USA - NYSEARCA:NAVB - US63937X2027 - Common Stock
We assign a technical rating of 0 out of 10 to NAVB. NAVB scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
NAVB has a poor technical rating and the quality of the setup is also only medium at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
0.08
We can see 3 important resistance areas.
- A resistance zone ranging from 0.09 to 0.09. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- A resistance zone ranging from 0.10 to 0.10. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- Resistance @0.12 from a horizontal line in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for NAVB is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for NAVB is down. |
| ChartMill Relative Strength | 9.44 | NEGATIVE | NAVB has a low relative strength, it was outperformed by 90.56% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of NAVB is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of NAVB is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of NAVB is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 40.32 | NEUTRAL | The RSI value for NAVB is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0 | NEGATIVE | The MACD value suggests NAVB has a negative trend. |
| Stochastics (14,3) | 4.34 | OVERSOLD | The low Stochastics value suggests NAVB may be oversold. |
| Average True Range in percent/ATR (20) | 17.21 | HIGH VOLATILITY | The high ATR as a percentage value for NAVB suggests high volalility. |
| Average Directional Index/ADX (14) | 23.14 | NEUTRAL | The ADX value for NAVB suggests a possible start of a new trend. |
NYSEARCA:NAVB (10/5/2023, 8:04:00 PM)
0.0779
0 (-2.99%)
NAVIDEA BIOPHARMACEUTICALS I / NAVB FAQ
What is the technical rating for NAVB stock?
ChartMill assigns a technical rating of 0 / 10 to NAVB.
Can you provide the trend direction for NAVIDEA BIOPHARMACEUTICALS I?
The current trend direction for NAVIDEA BIOPHARMACEUTICALS I (NAVB) is Bearish.
Can you provide the RSI signal for NAVIDEA BIOPHARMACEUTICALS I?
NAVIDEA BIOPHARMACEUTICALS I (NAVB) has an RSI value of 40.3157. This indicates that the stock is currently neutral.
Can you provide the short term momentum for NAVIDEA BIOPHARMACEUTICALS I?
The short term momentum for NAVIDEA BIOPHARMACEUTICALS I (NAVB) is negative.
Can you provide the buy/sell signal for NAVIDEA BIOPHARMACEUTICALS I?
The buy/sell signal for NAVIDEA BIOPHARMACEUTICALS I (NAVB) is sell as both the short term and long term trends are negative.